IPO of C4 Therapeutics, Inc.

C4 Therapeutics, Inc. has placed 9 600 000 shares of common stock in an IPO priced $19 per share, which is $1 above the upper limit of the previously announced range ($16-18). Besides, C4 Therapeutics has granted the underwriters a 30-day option to purchase up to 1 440 000 shares of common stock at the price of public offering. 
The trading debut will take place on October 2, 2020 under the ticker symbol “CCCC”.